Search research articles
Contact Us
Filters
Showing results (31-40 of 115) with videos related to
Page
of 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2016
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
Babak Behnam Azad, Ala Lisok, Samit Chatterjee, et al.
Nature Communications
|
December 10, 2025
SLFN11 counteracts the RFWD3-PRIMPOL DNA damage tolerance axis to restrain gapped DNA synthesis in response to replication stress
Kate E Coleman, Dong-Woo Shin, Liana Goehring, et al.
Clinical and Vaccine Immunology : CVI
|
October 17, 2014
Thermostable cross-protective subunit vaccine against Brucella species
John W Cherwonogrodzky, Nicole D Barabé, Michelle L Grigat, et al.
Cancer Research
|
March 12, 2014
Rapamycin rescues ABT-737 efficacy in small cell lung cancer
Eric E Gardner, Nick Connis, John T Poirier, et al.
Oncotarget
|
December 5, 2014
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
Frank P Vendetti, Michael Topper, Peng Huang, et al.
Nature Cancer
|
December 21, 2020
Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid <i>in vivo</i> functional genomics
Christopher H Hulton, Emily A Costa, Nisargbhai S Shah, et al.
The Journal of General Virology
|
September 14, 2012
Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001
John T Poirier, P Seshidhar Reddy, Neeraja Idamakanti, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
An enhanced Eco1 retron editor enables precision genome engineering in human cells from a single-copy integrated lentivirus
Matthew A Cattle, Lauren C Aguado, Samantha Sze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2011
Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features
Charles M Rudin, John T Poirier, Neil N Senzer, et al.
Pediatric Blood & Cancer
|
October 14, 2014
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group
Michael J Burke, Charlotte Ahern, Brenda J Weigel, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 115) with videos related to
Sort By:
Page
of 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 26, 2016
Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
Babak Behnam Azad, Ala Lisok, Samit Chatterjee, et al.
Nature Communications
|
December 10, 2025
SLFN11 counteracts the RFWD3-PRIMPOL DNA damage tolerance axis to restrain gapped DNA synthesis in response to replication stress
Kate E Coleman, Dong-Woo Shin, Liana Goehring, et al.
Clinical and Vaccine Immunology : CVI
|
October 17, 2014
Thermostable cross-protective subunit vaccine against Brucella species
John W Cherwonogrodzky, Nicole D Barabé, Michelle L Grigat, et al.
Cancer Research
|
March 12, 2014
Rapamycin rescues ABT-737 efficacy in small cell lung cancer
Eric E Gardner, Nick Connis, John T Poirier, et al.
Oncotarget
|
December 5, 2014
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer
Frank P Vendetti, Michael Topper, Peng Huang, et al.
Nature Cancer
|
December 21, 2020
Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid <i>in vivo</i> functional genomics
Christopher H Hulton, Emily A Costa, Nisargbhai S Shah, et al.
The Journal of General Virology
|
September 14, 2012
Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001
John T Poirier, P Seshidhar Reddy, Neeraja Idamakanti, et al.
Biorxiv : the Preprint Server for Biology
|
August 16, 2024
An enhanced Eco1 retron editor enables precision genome engineering in human cells from a single-copy integrated lentivirus
Matthew A Cattle, Lauren C Aguado, Samantha Sze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2011
Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features
Charles M Rudin, John T Poirier, Neil N Senzer, et al.
Pediatric Blood & Cancer
|
October 14, 2014
Phase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group
Michael J Burke, Charlotte Ahern, Brenda J Weigel, et al.
Page
of 12